The 6th Annual Psychedelic Therapeutics and Drug Development Conference

The 6th Annual Psychedelic Therapeutics and Drug Development Conference is dedicated to the research and development of psychedelics for various health conditions.

Topics

• Risk Evaluation and Mitigation Strategy (REMS)
• Clinical trial design
• Practical use/indications/
• Abuse potential
• Targets for novel drug development
• DEA licensure and policy considerations
• Second generation psychedelic drug design
• Dosage (micro/low/high)
• Toxicology studies and considerations
• FDA regulatory guidance

Who should Attend

• Vice Presidents
• Chief Executive Officers
• Business Development Professionals
• Chief Medical Officers
• Research Scientists
• Regulatory Affairs Professionals
• Clinical Development Professionals
• R&D Professionals
• Investigators
• Licensing Professionals
• Chemists
• Medical Chemists
• Scientists
• Pharmacists
• Project Managers
• Study Managers
• Professors
• Scientific Officers
• Health Care Practitioners
• Ph.D./Pharm.D. Students
• Investors
• Program Officers
• Medical Directors
• Analysts